1. Despite strong Q3 results, EverQuote's shares have drifted downward. 2. The company's revenue and variable marketing margin more than doubled in Q3. 3. The threat of Canada/Mexico tariffs may impact insurer profitability. 4. EverQuote is trading at a significant discount at ~8x forward adjusted EBITDA. 5. The author upgrades the stock rating to a strong buy.